Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like Reckitt CEO's $17B Predicament December 26, 2017 Eli Lilly Seeks "Voluntary Exits" From 200 Researchers February 5, 2017 pSivida To Report Fourth Quarter And Fiscal Year 2017 Financial Results On Monday, September 11th September 4, 2017
pSivida To Report Fourth Quarter And Fiscal Year 2017 Financial Results On Monday, September 11th September 4, 2017